A Retrospective

Striatal Glutamate Release in L-DOPA-Induced Dyskinetic Animals.

Published February 8, 2013

Striatal Glutamate Release in l-DOPA-Induced Dyskinetic Animals.

Filed under: Drug and Alcohol Rehabilitation

PLoS One. 2013; 8(2): e55706
Nevalainen N, Lundblad M, Gerhardt GA, Strömberg I

l-DOPA-induced dyskinesia is a common side effect developed after chronic treatment with 3,4-dihydroxyphenyl-l-alanine… Continue reading →

Fourth Metatarsal Base Stress Fractures in Athletes: A Case Series.

Published February 7, 2013

Fourth Metatarsal Base Stress Fractures in Athletes: A Case Series.

Filed under: Rehab Centers

Foot Ankle Int. 2013 Feb 5;
Rongstad KM, Tueting J, Rongstad M, Garrels K, Meis R

Background:Metatarsal stress fractures account for approximately 28% of all… Continue reading →

Issues in Localization of Brain Function: The Case of Lateralized Frontal Cortex in Cognition, Emotion, and Psychopathology.

Published February 7, 2013

Issues in localization of brain function: The case of lateralized frontal cortex in cognition, emotion, and psychopathology.

Filed under: Depression Treatment

Front Integr Neurosci. 2013; 7: 2
Miller GA, Crocker LD, Spielberg JM, Infantolino ZP, Heller W

The appeal… Continue reading →

Drug and Alcohol Rehabilitation: Therapeutic Application of Melatonin in Mild Cognitive Impairment.

Published February 6, 2013

Therapeutic application of melatonin in mild cognitive impairment.

Filed under: Drug and Alcohol Rehabilitation

Am J Neurodegener Dis. 2012; 1(3): 280-91
Cardinali DP, Vigo DE, Olivar N, Vidal MF, Furio AM, Brusco LI

Mild cognitive impairment (MCI) is an… Continue reading →

Medical Costs and Utilization in Patients With Depression Treated With Adjunctive Atypical Antipsychotic Therapy.

Published February 5, 2013

Medical costs and utilization in patients with depression treated with adjunctive atypical antipsychotic therapy.

Filed under: Depression Treatment

Clinicoecon Outcomes Res. 2013; 5: 49-57
Nadkarni A, Kalsekar I, You M, Forbes R, Hebden T

To compare total medical costs… Continue reading →

Eating Disorders: Promoviendo Una Alimentación Saludable (PAS) Design and Methods: Engaging Latino Families in Eating Disorder Treatment.

Published February 5, 2013

Promoviendo una Alimentación Saludable (PAS) Design and Methods: Engaging Latino Families in Eating Disorder Treatment.

Filed under: Eating Disorders

Contemp Clin Trials. 2013 Jan 31;
Reyes-Rodríguez ML, Bulik CM, Hamer RM, Baucom DH

The use of culturally sensitive intervention… Continue reading →

Drug and Alcohol Rehabilitation: New Models of Pulmonary Hypertension Based on VEGF Receptor Blockade-Induced Endothelial Cell Apoptosis.

Published February 2, 2013

New models of pulmonary hypertension based on VEGF receptor blockade-induced endothelial cell apoptosis.

Filed under: Drug and Alcohol Rehabilitation

Pulm Circ. 2012 10; 2(4): 434-442
Nicolls MR, Mizuno S, Taraseviciene-Stewart L, Farkas L, Drake JI, Al Husseini A, Gomez-Arroyo… Continue reading →

Modeling Cyclosporine a Inhibition of the Distribution of a P-Glycoprotein PET Ligand, 11C-Verapamil, Into the Maternal Brain and Fetal Liver of the Pregnant Nonhuman Primate: Impact of Tissue Blood Flow and Site of Inhibition.

Published January 30, 2013

Modeling Cyclosporine A Inhibition of the Distribution of a P-Glycoprotein PET Ligand, 11C-Verapamil, into the Maternal Brain and Fetal Liver of the Pregnant Nonhuman Primate: Impact of Tissue Blood Flow and Site of Inhibition.

Filed under: Drug and Alcohol Rehabilitation… Continue reading →

Safety of Besifloxacin Ophthalmic Suspension 0.6% in Refractive Surgery: A Retrospective Chart Review of Post-LASIK Patients.

Published January 30, 2013

Safety of besifloxacin ophthalmic suspension 0.6% in refractive surgery: a retrospective chart review of post-LASIK patients.

Filed under: Drug and Alcohol Rehabilitation

Clin Ophthalmol. 2013; 7: 149-56
Nielsen SA, McDonald MB, Majmudar PA

To evaluate the safety of besifloxacin… Continue reading →

Depression Treatment: Inflammation Subverts Hippocampal Synaptic Plasticity in Experimental Multiple Sclerosis.

Published January 29, 2013

Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis.

Filed under: Depression Treatment

PLoS One. 2013; 8(1): e54666
Nisticò R, Mango D, Mandolesi G, Piccinin S, Berretta N, Pignatelli M, Feligioni M, Musella A, Gentile A, Mori F, Bernardi… Continue reading →

Striatal Glutamate Release in L-DOPA-Induced Dyskinetic Animals.

Issues in Localization of Brain Function: The Case of Lateralized Frontal Cortex in Cognition, Emotion, and Psychopathology.

Drug and Alcohol Rehabilitation: Therapeutic Application of Melatonin in Mild Cognitive Impairment.

Eating Disorders: Promoviendo Una Alimentación Saludable (PAS) Design and Methods: Engaging Latino Families in Eating Disorder Treatment.

Drug and Alcohol Rehabilitation: New Models of Pulmonary Hypertension Based on VEGF Receptor Blockade-Induced Endothelial Cell Apoptosis.

Modeling Cyclosporine a Inhibition of the Distribution of a P-Glycoprotein PET Ligand, 11C-Verapamil, Into the Maternal Brain and Fetal Liver of the Pregnant Nonhuman Primate: Impact of Tissue Blood Flow and Site of Inhibition.

Depression Treatment: Inflammation Subverts Hippocampal Synaptic Plasticity in Experimental Multiple Sclerosis.

Recent Posts

Search this Site